Amanda Giddings is a seasoned expert in nonclinical toxicology and drug safety, currently serving as the VP Head of Project Toxicology and Discovery Safety at Evotec since January 2024. In this role, Amanda leads initiatives focused on scientific excellence and innovation throughout the drug development process. Amanda also contributes as a Scientific Advisory Board Member at Sable Bio, which aims to enhance drug safety predictions through advanced data insights. Previously, Amanda held key positions at BenevolentAI, including Director of Drug Discovery - Nonclinical Safety and Senior Principal Scientist, where efforts centered on integrating AI with drug discovery. Amanda's earlier career includes roles at GlaxoSmithKline as a Computational and Genetic Toxicologist, and research positions at Trigen Ltd and BIBRA International. Amanda earned a BSc in Biochemistry with Toxicology from the University of Surrey.
This person is not in any teams
This person is not in any offices